OSE Immunotherapeutics SA (EPA:OSE)
France flag France · Delayed Price · Currency is EUR
5.16
-0.35 (-6.35%)
Apr 4, 2025, 5:35 PM CET

OSE Immunotherapeutics Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
11315781123188129
Upgrade
Market Cap Growth
94.71%94.71%-34.73%-34.26%45.49%133.63%
Upgrade
Enterprise Value
142125109128184126
Upgrade
Last Close Price
5.167.174.286.6710.287.20
Upgrade
PE Ratio
3.494.19----
Upgrade
Forward PE
5.702.83----
Upgrade
PS Ratio
1.351.8836.176.747.1412.38
Upgrade
PB Ratio
1.772.463.513.783.922.10
Upgrade
P/TBV Ratio
2.462.463.533.803.932.10
Upgrade
P/FCF Ratio
2.333.24----
Upgrade
P/OCF Ratio
3.243.24----
Upgrade
EV/Sales Ratio
1.701.5049.076.997.0112.09
Upgrade
EV/EBITDA Ratio
2.852.54----
Upgrade
EV/EBIT Ratio
3.252.86----
Upgrade
EV/FCF Ratio
2.942.58----
Upgrade
Debt / Equity Ratio
0.720.721.991.370.780.32
Upgrade
Debt / EBITDA Ratio
0.920.92----
Upgrade
Debt / FCF Ratio
0.950.95----
Upgrade
Asset Turnover
0.810.810.030.190.270.11
Upgrade
Quick Ratio
1.031.031.401.972.362.57
Upgrade
Current Ratio
3.463.461.622.292.642.82
Upgrade
Return on Equity (ROE)
86.29%86.29%-82.69%-44.10%-30.85%-27.62%
Upgrade
Return on Assets (ROA)
26.53%26.53%-16.53%-11.93%-10.45%-12.77%
Upgrade
Return on Capital (ROIC)
30.59%30.59%-19.65%-14.21%-12.53%-15.73%
Upgrade
Return on Capital Employed (ROCE)
42.20%42.20%----
Upgrade
Earnings Yield
33.18%23.88%-28.56%-14.39%-8.98%-12.83%
Upgrade
FCF Yield
42.85%30.84%-24.56%-15.01%-5.54%-15.32%
Upgrade
Buyback Yield / Dilution
-29.34%-29.34%-5.58%-2.05%-16.71%-4.46%
Upgrade
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.